Myths vs. Facts: Getting Rezlidhia (olutasidenib) Covered by Aetna (CVS Health) in North Carolina
Answer Box: Fast Path to Rezlidhia Coverage in North Carolina
Rezlidhia (olutasidenib) requires prior authorization from Aetna (CVS Health) for adults ≥18 with confirmed relapsed/refractory IDH1-mutated AML. Submit complete documentation including FDA-approved IDH1 mutation test results, treatment history, and oncologist prescription via CVS Caremark (1-855-344-0930) or Aetna provider portal.